The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. - Wikidata - wikimedia - TriplyDB

The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.

The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.

http://www.wikidata.org/entity/Q33852836

about

Angioedema related to Angiotensin inhibitors.Angioedema in the emergency department: a practical guide to differential diagnosis and management.The past, present and future of renin-angiotensin aldosterone system inhibition Angioedema due to fixed dose combination of telmisartan plus ramipril Drug-induced visceral angioedema.Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal.An Unusual Case of Angiotensin-Converting-Enzyme Inhibitor-Related Penile Angioedema with Evolution to the Oropharynx Angioedema associated with the use of angiotensin-converting enzyme inhibitor Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Angiotensin converting enzyme inhibitor-related angioedema: onset, presentation, and management.Tolerability of Antihypertensive Medications in Older Adults.Hypertension in Athletes and Active Populations.Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database.Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.Treatment of angiotensin receptor blocker-induced angioedema: A case series.Intraoperative angioedema induced by angiotensin II receptor blocker: a case report

P2860

Q30458886-087BC8CC-4D36-4F5F-9964-CAF8121050C6 Q33559121-C5BF1FCE-CF6C-4F03-BFDF-C2A150013D5C Q34094354-3488A71B-F121-422D-ADB6-8D83FD5673C6 Q34145076-FFA2262D-3CD3-4C66-81FB-79EE73C6A6EA Q34288820-8070DBEF-B4BA-47EF-9110-4FF66EAB346B Q35155766-AC3A1BC1-6417-4479-829A-3A188D91063D Q36435922-C207ED9E-6D20-461C-8FC9-43B982ED752B Q36510768-6CAB77A6-FFCB-4D20-9500-3213DFCBA23D Q38042696-725DE121-FD81-4ED3-A489-44D7042BD013 Q38233590-F87345C0-5751-459A-8941-76F1F70AEB24 Q38600758-A44AC95F-F858-4594-9346-97D9A4BBE192 Q38980060-3556BC90-012B-4E1C-BE5E-1D371E8157F1 Q41018758-C6078D72-FA6E-4A97-9235-3D9BF5AAB3E1 Q49545608-7891650E-240D-41B3-92EC-A8D47A5FBC72 Q53621000-B946703B-ADB3-4FAC-8190-7346EF3C1E13 Q58714015-1BA73308-7A6A-4845-8408-82D80AEA67ED

P2860

The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.

http://www.wikidata.org/entity/Q33852836

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The role of angiotensin recept ...... inhibitor-induced angioedema.

@ast

The role of angiotensin recept ...... inhibitor-induced angioedema.

@en

type

label

The role of angiotensin recept ...... inhibitor-induced angioedema.

@ast

The role of angiotensin recept ...... inhibitor-induced angioedema.

@en

prefLabel

The role of angiotensin recept ...... inhibitor-induced angioedema.

@ast

The role of angiotensin recept ...... inhibitor-induced angioedema.

@en

P1433

Q33852836-2C8B477D-38FF-4470-A007-931D7646AD67

P1476

Q33852836-537055CA-EFF2-44E9-BE1A-94E11407F3C9

P2093

Q33852836-71276AE6-35C4-4096-BEBD-DE2D6627BE76

Q33852836-7F40CB2F-62E2-4B82-A34F-78EC76192C4E

Q33852836-C914B3A1-ADBA-4557-9F83-16A13F662ECB

P2860

Q33852836-0B543D42-08C0-4C3E-9FE5-69FA1EC1C62E

Q33852836-13E91543-13A1-4CA6-BFE8-70C8E0B2DCAF

Q33852836-190AF812-7922-4AE1-8844-93367C6264BE

Q33852836-1A169474-22DD-457D-9121-B705DBB05EE8

Q33852836-4A8BB0C4-FD09-4E8C-B7CC-7CFAAB7F4244

Q33852836-639FEEA3-A129-470C-900A-041FAFDE1EAE

Q33852836-6CF7A166-4C53-4B56-9D26-5979E7FF37A7

Q33852836-723101D9-B0D6-4E51-8DE0-48685AC28F6F

Q33852836-8974CBF2-04A6-4BB6-886C-4F4BF2D6CA40

Q33852836-B5D1B53C-FE80-4D68-91B4-64443A5CF24F

P304

Q33852836-352C130E-5352-4FB7-BE64-E63345FFDEEB

P31

Q33852836-685DCD34-B6FE-47B6-BBC7-2DBF94A5D9B5

P356

Q33852836-B6680476-A054-479D-A6F3-5329045733CC

P407

Q33852836-7DC0655F-287B-4DA1-A159-B23BBEB4E614

P433

Q33852836-68A7CA5E-AFA9-450F-8A57-D1293639A29D

P478

Q33852836-FB1D8285-FEAB-45F4-99F6-E140262C7491

P577

Q33852836-EDC21FF5-E6A5-44B9-8C99-EFD5FFA70763

P698

Q33852836-9AB5979F-2385-4D43-8D19-594A557161B1

P356

P1433

Annals of Pharmacotherapy

P1476

The role of angiotensin recept ...... inhibitor-induced angioedema.

@en

P2093

Craig James Beavers

http://www.w3.org/2001/XMLSchema#string

Steven P Dunn

http://www.w3.org/2001/XMLSchema#string

Tracy E Macaulay

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.

Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis.

Strengths and limitations of meta-analysis: larger studies may be more reliable.

Angiotensin receptors and their antagonists.

Angioneurotic edema attributed to the use of losartan.

P304

520-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1P630

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21427294

http://www.w3.org/2001/XMLSchema#string